Abstract
DRG neurones are a heterogeneous population of neurones that vary in sensory transduction mechanisms, myelination, axon diameter, cell soma size, neurotransmitter content, receptor and ion channel expression. The generation, conduction, integration and transmission of pain signals begin in DRG neurones and they remain an important target for therapeutic intervention in pain disorders. In this review we discuss the expression of cannabinoid receptors in DRG neurones. We will also discuss the actions and molecular mechanisms of cannabinoid receptor ligands in the context of modulating sensory neurone excitability. Evidence suggests that vanilloid and cytokine receptor functions, voltageactivated Ca2+ and K + channels and Ca2+-activated channels are all either direct or indirect sites that might be modulated by synthetic and endogenous cannabinoid ligands.
Keywords: Neurones, heterogeneous, myelination
Current Neuropharmacology
Title: Cannabinoids and Sensory Neurones
Volume: 2 Issue: 1
Author(s): Ruth A. Ross, Rhian M. Evans and Roderick H. Scott
Affiliation:
Keywords: Neurones, heterogeneous, myelination
Abstract: DRG neurones are a heterogeneous population of neurones that vary in sensory transduction mechanisms, myelination, axon diameter, cell soma size, neurotransmitter content, receptor and ion channel expression. The generation, conduction, integration and transmission of pain signals begin in DRG neurones and they remain an important target for therapeutic intervention in pain disorders. In this review we discuss the expression of cannabinoid receptors in DRG neurones. We will also discuss the actions and molecular mechanisms of cannabinoid receptor ligands in the context of modulating sensory neurone excitability. Evidence suggests that vanilloid and cytokine receptor functions, voltageactivated Ca2+ and K + channels and Ca2+-activated channels are all either direct or indirect sites that might be modulated by synthetic and endogenous cannabinoid ligands.
Export Options
About this article
Cite this article as:
Ross A. Ruth, Evans M. Rhian and Scott H. Roderick, Cannabinoids and Sensory Neurones, Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476882
DOI https://dx.doi.org/10.2174/1570159043476882 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies
Current Pharmaceutical Design Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond
Current Drug Targets Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells
Current Molecular Medicine Recent Patents of Gene Sequences Relative to the Phosphatidylinositol 3-kinase / Akt Pathway and their Relevance to Drug Discovery
Recent Patents on DNA & Gene Sequences Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Current Medicinal Chemistry Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Current Neurovascular Research Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry Anticarcinogenic Actions of Tributyrin, A Butyric Acid Prodrug
Current Drug Targets Multimodality Imaging of CXCR4 in Cancer: Current Status towards Clinical Translation
Current Molecular Medicine MET and ALK as Targets for the Treatment of NSCLC
Current Pharmaceutical Design Xanthone Derivatives: New Insights in Biological Activities
Current Medicinal Chemistry Lipid Based Anti-Retroviral Nanocarriers: A Review of Current Literature and Ongoing Studies
Drug Delivery Letters Targeting Death Receptors to Fight Cancer: From Biological Rational to Clinical Implementation
Current Medicinal Chemistry Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
Current Pharmaceutical Design Fetal Mesenchymal Stem Cells in Cancer Therapy
Current Stem Cell Research & Therapy Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
Current Drug Delivery